The DOI matches its Crossref record; 105 of the 105 references it cites were found in a registry or an index.
Chitosan in nasal delivery systems for therapeutic drugs
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The blood-brain barrier: Bottleneck in brain drug development
Pardridge, W. M. (2005) · NeuroRX · doi:10.1602/neurorx.2.1.3 · Cited by 2,798
Translocation of inhaled ultrafine particles to the brain
Oberdörster, G., Sharp, Z., Atudorei, V., Elder, A., Gelein, R., Kreyling, W., & Cox, C. (2004) · Inhalation Toxicology · doi:10.1080/08958370490439597 · Cited by 2,606
Chitosan and Its Use as a Pharmaceutical Excipient
Ilium, L. (1998) · Pharmaceutical Research · doi:10.1023/a:1011929016601 · Cited by 1,396
Nasal drug delivery—possibilities, problems and solutions
Illum, L. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00363-2 · Cited by 1,102
Self-citationHydrodynamic Radii of Native and Denatured Proteins Measured by Pulse Field Gradient NMR Techniques
Wilkins, D. K., Grimshaw, S. B., Receveur, V., Dobson, C. M., Jones, J. A., & Smith, L. J. (1999) · Biochemistry · doi:10.1021/bi991765q · Cited by 1,010
Transport of drugs from the nasal cavity to the central nervous system
Illum, L. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00087-7 · Cited by 907
Self-citationRecent advances of chitosan nanoparticles as drug carriers
Zeng, Z. (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s17296 · Cited by 665
Chitosan as a Novel Nasal Delivery System for Peptide Drugs
Illum, L., Farraj, N. F., & Davis, S. S. (1994) · Pharmaceutical Research · doi:10.1023/a:1018901302450 · Cited by 629
Self-citationChitosan Reduced Gold Nanoparticles as Novel Carriers for Transmucosal Delivery of Insulin
Bhumkar, D. R., Joshi, H. M., Sastry, M., & Pokharkar, V. B. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9257-9 · Cited by 624
Intranasal delivery: Physicochemical and therapeutic aspects
Costantino, H. R., Illum, L., Brandt, G., Johnson, P. H., & Quay, S. C. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.03.025 · Cited by 598
Self-citationEnhancement of Nasal Absorption of Insulin Using Chitosan Nanoparticles
Fernández-Urrusuno, R., Calvo, P., Remuñán-López, C., Vila-Jato, J. L., & José Alonso, M. (1999) · Pharmaceutical Research · doi:10.1023/a:1018908705446 · Cited by 587
The safety of chitosan as a pharmaceutical excipient
Baldrick, P. (2010) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2009.09.015 · Cited by 569
Delivery of Neurotrophic Factors to the Central Nervous System: Pharmacokinetic Considerations
Thorne, R. G., & Frey, W. H. (2001) · Clinical Pharmacokinetics · doi:10.2165/00003088-200140120-00003 · Cited by 487
Effect of Chitosan on Epithelial Cell Tight Junctions
Smith, J., Wood, E., & Dornish, M. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000012150.60180.e3 · Cited by 467
Is nose-to-brain transport of drugs in man a reality?
Illum, L. (2004) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357022539 · Cited by 439
Self-citationIntranasal nanoemulsion based brain targeting drug delivery system of risperidone
Kumar, M., Misra, A., Babbar, A. K., Mishra, A. K., Mishra, P., & Pathak, K. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.03.029 · Cited by 435
Amidi, M., Romeijn, S. G., Borchard, G., Junginger, H. E., Hennink, W. E., & Jiskoot, W. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.11.014 · Cited by 415
Molecular structure and assembly of the tight junction
Denker, B. M., & Nigam, S. K. (1998) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1998.274.1.f1 · Cited by 404
Development and evaluation of rivastigmine loaded chitosan nanoparticles for brain targeting
Fazil, M., Md, S., Haque, S., Kumar, M., Baboota, S., Sahni, J. K., & Ali, J. (2012) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2012.04.013 · Cited by 379
Wu, J., Wei, W., Wang, L.-Y., Su, Z.-G., & Ma, G.-H. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2006.12.024 · Cited by 336
Md, S., Khan, R. A., Mustafa, G., Chuttani, K., Baboota, S., Sahni, J. K., & Ali, J. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2012.12.007 · Cited by 306
Preparation of estradiol chitosan nanoparticles for improving nasal absorption and brain targeting
Wang, X., Chi, N., & Tang, X. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.07.005 · Cited by 305
Sood, S., Jain, K., & Gowthamarajan, K. (2014) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2013.09.030 · Cited by 289
Nasal drug delivery — Recent developments and future prospects
Illum, L. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.01.024 · Cited by 287
Self-citationDyer, A. M., Hinchcliffe, M., Watts, P., Castile, J., Jabbal-Gill, I., Nankervis, R., Smith, A., & Illum, L. (2002) · Pharmaceutical Research · doi:10.1023/a:1016418523014 · Cited by 280
Self-citationvan der Lubben, I. (2001) · Biomaterials · doi:10.1016/s0142-9612(00)00231-3 · Cited by 280
Tight junction modulation by chitosan nanoparticles: Comparison with chitosan solution
Vllasaliu, D., Exposito-Harris, R., Heras, A., Casettari, L., Garnett, M., Illum, L., & Stolnik, S. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.08.020 · Cited by 252
Self-citationDrug Metabolism in the Nasal Mucosa
Sarkar, M. A. (1992) · Pharmaceutical Research · doi:10.1023/a:1018911206646 · Cited by 250
Chitosan-Alginate Blended Nanoparticles as Carriers for the Transmucosal Delivery of Macromolecules
Goycoolea, F. M., Lollo, G., Remuñán-López, C., Quaglia, F., & Alonso, M. J. (2009) · Biomacromolecules · doi:10.1021/bm9001377 · Cited by 238
New method for the quaternization of chitosan
Domard, A., Rinaudo, M., & Terrassin, C. (1986) · International Journal of Biological Macromolecules · doi:10.1016/0141-8130(86)90007-3 · Cited by 237
Nanoparticulate Systems for Nasal Delivery of Drugs: A Real Improvement over Simple Systems?
Illum, L. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20718 · Cited by 237
Self-citationSchaefer, M. L., Böttger, B., Silver, W. L., & Finger, T. E. (2002) · Journal of Comparative Neurology · doi:10.1002/cne.10143 · Cited by 237
PEGylated chitosan derivatives: Synthesis, characterizations and pharmaceutical applications
Casettari, L., Vllasaliu, D., Castagnino, E., Stolnik, S., Howdle, S., & Illum, L. (2012) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2011.10.001 · Cited by 232
Self-citationKim, J.-Y., Choi, W. I., Kim, Y. H., & Tae, G. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2012.09.047 · Cited by 219
Nasal pH measurement: a reliable and repeatable parameter
England, R. J. A., Homer, J. J., Knight, L. C., & Ell, S. R. (1999) · Clinical Otolaryngology and Allied Sciences · doi:10.1046/j.1365-2273.1999.00223.x · Cited by 207
Nasal Route for Direct Delivery of Solutes to the Central Nervous System: Fact or Fiction?
Mathison, S., Nagilla, R., & Kompella, U. B. (1998) · Journal of Drug Targeting · doi:10.3109/10611869808997870 · Cited by 200
Nasal absorption enhancement of insulin using PEG-grafted chitosan nanoparticles
ZHANG, X. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.08.009 · Cited by 197
Hinchcliffe, M., & Illum, L. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00073-8 · Cited by 180
Self-citationMucoadhesive nanoemulsion-based intranasal drug delivery system of olanzapine for brain targeting
Kumar, M., Misra, A., Mishra, A. K., Mishra, P., & Pathak, K. (2008) · Journal of Drug Targeting · doi:10.1080/10611860802476504 · Cited by 179
Clearance characteristics of chitosan based formulations in the sheep nasal cavity
Soane, R. J., Hinchcliffe, M., Davis, S. S., & Illum, L. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00602-0 · Cited by 172
Self-citationNasal administration of Carbamazepine using chitosan microspheres: In vitro/in vivo studies
GAVINI, E., HEGGE, A., RASSU, G., SANNA, V, TESTA, C., PIRISINO, G., KARLSEN, J., & GIUNCHEDI, P. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.09.013 · Cited by 170
Venlafaxine loaded chitosan NPs for brain targeting: Pharmacokinetic and pharmacodynamic evaluation
Haque, S., Md, S., Fazil, M., Kumar, M., Sahni, J. K., Ali, J., & Baboota, S. (2012) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2012.02.051 · Cited by 164
Mao, S., Germershaus, O., Fischer, D., Linn, T., Schnepf, R., & Kissel, T. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-8175-y · Cited by 164
Intranasal Delivery of Morphine
Illum, L., Watts, P., Fisher, A. N., Hinchcliffe, M., Norbury, H., Jabbal-Gill, I., Nankervis, R., & Davis, S. S. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.1.391 · Cited by 160
Self-citationChitosan‐NAC nanoparticles as a vehicle for nasal absorption enhancement of insulin
Wang, X., Zheng, C., Wu, Z., Teng, D., Zhang, X., Wang, Z., & Li, C. (2008) · Journal of Biomedical Materials Research Part B Applied Biomaterials · doi:10.1002/jbm.b.31161 · Cited by 147
Teijeiro‐Osorio, D., Remuñán‐López, C., & Alonso, M. J. (2008) · Biomacromolecules · doi:10.1021/bm800975j · Cited by 141
Involvement of protein kinase C in chitosan glutamate-mediated tight junction disruption
Smith, J. M., Dornish, M., & Wood, E. J. (2004) · Biomaterials · doi:10.1016/j.biomaterials.2004.06.020 · Cited by 138
New Technologies for Drug Delivery Across the Blood Brain Barrier
Kabanov, A. V., & Batrakova, E. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043384826 · Cited by 137
Finger, T. E., Jeor, V. L. S., Kinnamon, J. C., & Silver, W. L. (1990) · The Journal of Comparative Neurology · doi:10.1002/cne.902940212 · Cited by 127
Thiolated chitosan microparticles: A vehicle for nasal peptide drug delivery
Krauland, A. H., Guggi, D., & Bernkop‐Schnürch, A. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.10.016 · Cited by 126
Benediktsdóttir, B. E., Baldursson, Ó., & Másson, M. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.10.022 · Cited by 119
Nagpal, K., Singh, S. K., & Mishra, D. N. (2013) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2013.04.024 · Cited by 116
Nasal insulin delivery in the chitosan solution: in vitro and in vivo studies
Shao-yun, Y., Zhao, Y. H., Feng-lan, W., Zhang, X., Lü, W.-L., Zhang, H., & Zhang, Q. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.05.007 · Cited by 116
Al-Ghananeem, A. M., Saeed, H. M., Florence, R. L., Yokel, R. A., & Malkawi, A. H. (2009) · Journal of drug targeting · doi:10.3109/10611860903483396 · Cited by 116
Shahnaz, G., Vetter, A., Barthelmes, J., Rahmat, D., Laffleur, F., Iqbal, J., Perera, G., Schlocker, W., Dünnhaput, S., Augustijns, P., et al. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.02.044 · Cited by 116
Freeze-dried chitosan/pectin nasal inserts for antipsychotic drug delivery
Luppi, B., Bigucci, F., Abruzzo, A., Corace, G., Cerchiara, T., & Zecchi, V. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.04.013 · Cited by 114
Bshara, H., Osman, R., Mansour, S., & El-Shamy, A. E.-H. A. (2013) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2013.08.027 · Cited by 113
Charlton, S. T., Jones, N. S., Davis, S. S., & Illum, L. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2006.11.018 · Cited by 113
Self-citationEffect of PEGylation on the Toxicity and Permeability Enhancement of Chitosan
Casettari, L., Vllasaliu, D., Mantovani, G., Howdle, S. M., Stolnik, S., & Illum, L. (2010) · Biomacromolecules · doi:10.1021/bm100522c · Cited by 112
Self-citationPreparation of zolmitriptan–chitosan microparticles by spray drying for nasal delivery
Alhalaweh, A., Andersson, S., & Velaga, S. P. (2009) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2009.07.003 · Cited by 110
Evaluation of neuropeptide loaded trimethyl chitosan nanoparticles for nose to brain delivery
Kumar, M., Pandey, R. S., Patra, K. C., Jain, S. K., Soni, M. L., Dangi, J. S., & Madan, J. (2013) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2013.06.041 · Cited by 102
Chitosan and Its Use in Design of Insulin Delivery System
Wong, T. W. (2009) · Recent Patents on Drug Delivery & Formulation · doi:10.2174/187221109787158346 · Cited by 93
Kotzé, A. F., Thanou, M. M., Lueßen, H. L., de Boer, (. G., Verhoef, J. C., & Junginger, H. E. (1999) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(99)00006-5 · Cited by 90
Nasal Delivery of Insulin Using Bioadhesive Chitosan Gels
Varshosaz, J., Sadrai, H., & Heidari, A. (2006) · Drug Delivery · doi:10.1080/10717540500309040 · Cited by 89
Cho, H., Balakrishnan, P., Park, E.-K., Song, K., Hong, S., Jang, T.-Y., Kim, K., Chung, S., Shim, C., & Kim, D. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22314 · Cited by 89
Nasal delivery of insulin using chitosan microspheres
Varshosaz, J., Sadrai, H., & Alinagari, R. (2004) · Journal of Microencapsulation · doi:10.1080/02652040400015403 · Cited by 84
Gavini, E., Rassu, G., Muzzarelli, C., Cossu, M., & Giunchedi, P. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.05.002 · Cited by 83
Charlton, S. T., Davis, S. S., & Illum, L. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.12.014 · Cited by 81
Self-citationMei, D. F., Mao, S., Sun, W., et al. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.06.031 · Cited by 79
Pilot Study of Nasal Morphine-Chitosan for the Relief of Breakthrough Pain in Patients With Cancer
Pavis, H., Wilcock, A., Edgecombe, J., Carr, D., Manderson, C., Church, A., & Fisher, A. N. (2002) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(02)00522-5 · Cited by 79
Bioavailability enhancement of verapamil HCl via intranasal chitosan microspheres
Mouez, M. A., Zaki, N. M., Mansour, S., & Geneidi, A. S. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.08.029 · Cited by 79
Mucoadhesive chitosan microspheres of carvedilol for nasal administration
Patil, S. B., Babbar, A. K., Mathur, R., Mishra, A. K., & Sawant, K. K. (2010) · Journal of drug targeting · doi:10.3109/10611861003663523 · Cited by 78
Brain uptake of an anti-ischemic agent by nasal administration of microparticles
Dalpiaz, A., Gavini, E., Colombo, G., Russo, P., Bortolotti, F., Ferraro, L., Tanganelli, S., Scatturin, A., Menegatti, E., & Giunchedi, P. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21335 · Cited by 76
Vaka, S. R. K., Sammeta, S. M., Day, L. B., & Murthy, S. N. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21674 · Cited by 75
Intranasal Delivery of Chitosan Nanoparticles for Migraine Therapy
Gulati, N., Nagaich, U., & Saraf, S. A. (2013) · Scientia Pharmaceutica · doi:10.3797/scipharm.1208-18 · Cited by 71
Chitosan microspheres as a delivery system for nasal insufflation
Patil, S. B., & Sawant, K. K. (2011) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2011.01.030 · Cited by 71
Sun, Y., Cui, F., Shi, K., Wang, J., Niu, M., & Ma, R. (2008) · Drug Development and Industrial Pharmacy · doi:10.1080/03639040802395185 · Cited by 70
Regulation of the intestinal epithelial paracellular barrier
Daugherty, A. L., & Mrsny, R. J. (1999) · Pharmaceutical Science & Technology Today · doi:10.1016/s1461-5347(99)00170-4 · Cited by 69
Gavini, E., Rassu, G., Ferraro, L., Beggiato, S., Alhalaweh, A., Velaga, S., Marchetti, N., Bandiera, P., Giunchedi, P., & Dalpiaz, A. (2013) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2012.10.010 · Cited by 62
Patel, D. H., Naik, S., & Misra, A. R. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22780 · Cited by 56
Insulin Transport within Skeletal Muscle Transverse Tubule Networks
Shorten, P. R., McMahon, C. D., & Soboleva, T. K. (2007) · Biophysical Journal · doi:10.1529/biophysj.107.107888 · Cited by 55
Nasal and rectal delivery of insulin with chitosan and N-trimethyl chitosan chloride
Plessis, D., Kotzé, A. F., & Junginger, H. E. (2010) · Drug Delivery · doi:10.3109/10717541003762888 · Cited by 55
Thermo-sensitive gels containing lorazepam microspheres for intranasal brain targeting
Jose, S., Ansa, C. R., Cinu, T. A., Chacko, A. J., Aleykutty, N., Ferreira, S. V., & Souto, E. B. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.10.049 · Cited by 54
Gavini, E., Rassu, G., Ferraro, L., Generosi, A., Rau, J. V., Brunetti, A., Giunchedi, P., & Dalpiaz, A. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22382 · Cited by 54
Na, L., Mao, S., Wang, J., & Sun, W. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.06.048 · Cited by 52
Stoker, D. G., Reber, K. R., Waltzman, L. S., Ernst, C. C., Hamilton, D. A., Gawarecki, D., Mermelstein, F. H., McNicol, E. D., Wright, C., & Carr, D. B. (2007) · Pain Medicine · doi:10.1111/j.1526-4637.2007.00300.x · Cited by 51
Intranasal Drug Delivery to the Central Nervous System: Present Status and Future Outlook
Tayebati, S. K., Nwankwo, I. E., & Amenta, F. (2012) · Current Pharmaceutical Design · doi:10.2174/138161213804143662 · Cited by 49
Bahadur, S., & Pathak, K. (2012) · Current Drug Delivery · doi:10.2174/156720112803529792 · Cited by 46
Rassu, G., Gavini, E., Jonassen, H., Zambito, Y., Fogli, S., Breschi, M. C., & Giunchedi, P. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21751 · Cited by 46
Popov, M., Hammad, I. A., Bachar, T., Grinberg, S., Linder, C., Stepensky, D., & Heldman, E. (2013) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2013.06.005 · Cited by 46
Cheng, Y.-H., Dyer, A. M., Jabbal‐Gill, I., Hinchcliffe, M., Nankervis, R., Smith, A. M., & Watts, P. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.03.014 · Cited by 45
Rapid-onset intranasal delivery of metoclopramide hydrochloride
Zaki, N. M., Awad, G. A. S., Mortada, N. D., & ElHady, S. S. A. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.07.040 · Cited by 41
Patel, D. H., Naik, S., Chuttani, K., Mathur, R., Mishra, A. K., & Misra, A. R. (2013) · Journal of drug targeting · doi:10.3109/1061186x.2013.818676 · Cited by 38
Accessing the Brain: The Nose may Know the Way
Djupesland, P. G., Mahmoud, R. A., & Messina, J. C. (2013) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2013.41 · Cited by 34
Nazar, H., Caliceti, P., Carpenter, B. G., El‐Mallah, A., Fatouros, D. G., Roldo, M., van der Merwe, S. M., & Tsibouklis, J. (2012) · Biomaterials Science · doi:10.1039/c2bm00132b · Cited by 33
Wang, J., Lü, W.-L., Liang, G., Wu, K.-C., Zhang, C., Zhang, X., Wang, J., Zhang, H., Wang, X., & Zhang, Q. (2005) · Peptides · doi:10.1016/j.peptides.2005.09.008 · Cited by 31
Na, L., Wang, J., Wang, L., & Mao, S. (2012) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2012.10.030 · Cited by 25
NASAL ADMINISTRATION OF MORPHINE-6-GLUCURONIDE IN SHEEP—A PHARMACOKINETIC STUDY
Illum, L., Davis, S. S., Pawula, M., Fisher, A. N., Barrett, D. A., Farraj, N. F., & Shaw, P. N. (1996) · Biopharmaceutics & Drug Disposition · Cited by 23
Self-citationPalmberger, T. F., Augustijns, P., Vetter, A., & Bernkop‐Schnürch, A. (2011) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2011.584537 · Cited by 23
Delivery of cefotaxime to the brain via intranasal administration
Manda, P., Hargett, J. K., Vaka, S. R. K., Repka, M. A., & Murthy, S. N. (2011) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2011.571696 · Cited by 23
Al-Ghananeem, A. M., Malkawi, A. H., & Crooks, P. A. (2011) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2010.513009 · Cited by 21
Illum, L., Hinchcliffe, M., & Davis, S. S. (2003) · Pharmaceutical Research · doi:10.1023/a:1025722614154 · Cited by 18
Self-citationCho, H., Balakrishnan, P., Chung, S.-J., Shim, C., & Kim, D. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.06.009 · Cited by 17
Chitosan as a Delivery System for the Transmucosal Administration of Drugs
Illum, L., & Davis, S. S. (2004) · Polysaccharides · doi:10.1201/9781420030822.ch27 · Cited by 17
Self-citationBiological and Pharmacological Activity of Chitosan and Derivatives
Cunha, T., Teixeira, B., Santos, B., Almeida, M., Dias, G., & das Neves, J. (2012) · Wiley eBooks · doi:10.1002/9781119962977.ch5 · Cited by 15
Cited by
Kamaly, N., Yameen, B., Wu, J., & Farokhzad, O. C. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00346 · Cited by 3,070
An Overview of Chitosan Nanoparticles and Its Application in Non-Parenteral Drug Delivery
Mohammed, M., Syeda, J., Wasan, K., & Wasan, E. (2017) · Pharmaceutics · doi:10.3390/pharmaceutics9040053 · Cited by 1,362
Chitosan as a Wound Dressing Starting Material: Antimicrobial Properties and Mode of Action
Matica, M. A., Aachmann, F. L., Tøndervik, A., Sletta, H., & Ostafe, V. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20235889 · Cited by 818
Current Advances in Chitosan Nanoparticles Based Drug Delivery and Targeting
Garg, U., Chauhan, S., Nagaich, U., & Jain, N. (2019) · Advanced Pharmaceutical Bulletin · doi:10.15171/apb.2019.023 · Cited by 505
Harugade, A., Sherje, A. P., & Pethe, A. (2023) · Reactive and Functional Polymers · doi:10.1016/j.reactfunctpolym.2023.105634 · Cited by 474
Metadata
- Authors
- Casettari, L., & Illum, L.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2014-09
- Volume
- 190
- Pages
- 189-200
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W2071133343
- Cited by
- 444
- References
- 105
- FWCI
- 14.78
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.